Comparative Clinical Outcomes After Intra-articular Injection With Adipose-Derived Cultured Stem Cells or Noncultured Stromal Vascular Fraction for the Treatment of Knee Osteoarthritis: Letter to the Editor
Restricted accessLetterFirst published online February, 2020
Comparative Clinical Outcomes After Intra-articular Injection With Adipose-Derived Cultured Stem Cells or Noncultured Stromal Vascular Fraction for the Treatment of Knee Osteoarthritis: Letter to the Editor
CodinachMBlancoMTorricoC, et al. Validation and GMP production of mesenchymal stromal cells batches for clinical application in orthopedics and rheumatology. Cytotherapy. 2014;16:S45-S46.
2.
FreitagJBatesDBoydR, et al. Mesenchymal stem cell therapy in the treatment of osteoarthritis: reparative pathways, safety and efficacy—a review. BMC Musculoskelet Disord. 2016;17:230.
3.
GordonATKwangH. Fisioterapia después de intervenciones de medicina regenerativa. In: Malanga GA, Ibrahim V. Tratamientos regenerativos en medicina del deporte y traumatología. New York, NY: Elsevier; 2018;257-282.
4.
RodeoSA. Biologic approaches in sports medicine: potential, perils, and paths forward. Am J Sports Med. 2016;44(7):1657-1659.
5.
VivesJOliver-VilaIPlaA. Quality compliance in the shift from cell transplantation to cell therapy in non-pharma environments. Cytotherapy. 2015;17(8):1009-1014.
6.
YokotaNHattoriMOhtsuruT, et al. Comparative clinical outcomes after intra-articular injection with adipose-derived cultured stem cells or noncultured stromal vascular fraction for the treatment of knee osteoarthritis. Am J Sports Med. 2019;47(11):2577-2583.
